Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$182.50
+$0.00 (+0.0%)
Closing Price on July 28, 2021

ALXN Articles

24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The January 31 short interest data have been compared with the previous report, and short interest in...
The January 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
The December 14 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Many Wall Street firms are issuing their top picks and listing their favorite sectors and trends to consider for the year ahead. Credit Suisse is one of those firms.
The November 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
The October 31 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
The October 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks increased.
Alexion Pharmaceuticals reported better-than-expected quarterly results before the markets opened on Wednesday.
Here is a preview of some of the world’s largest players in the health care sector reporting earnings this coming week.
The September 28 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
Wednesday was a flat day for the broad U.S. markets. All three major indices had a positive start to the day but lost most of their gains the last hour of trading. Crude oil backed off in the...
The September 14 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.
24/7 Wall St. has reviewed the top biotech companies, without focusing on speculative companies. The August 31 short interest data have been compared with the previous report, and short interest in...
The August 15 short interest data have been compared with the previous report, and short interest in most of the selected biotech stocks decreased.